Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Vote In favor of Your Number one Sort Of Blossoms - 26 Nations for Setting up camp
- 3Parents search for children missing since a volcanic eruption in Colombia 40 years ago
- 4Artemis II astronauts will see parts of the moon no human has before. Here’s how
- 5Rediscovering Euphoria: Individual Accounts of Conquering Despondency
- NASA releases stunning new images captured by the Artemis II moon mission, including 'Earthset' and a solar eclipse from space
- Polish law aimed at lowering petrol prices takes effect
- Al-Sharaa denies he called for 80% of Syrians to return from Germany
- My skin feels drier, my lips thinner and my makeup heavier. How do I adjust my routine for aging skin?
- Most loved Web-based feature: Which Stage Do You Like
- Figure out how to Detect the Best Rooftop Substitution Choices
- How a seabird native to Hawaii has adapted to life in Honolulu's concrete jungle
- Exploring Programming Greatness: A Survey of \Easy to use Connection points\
- Five killed in Israeli air strikes on tents near Khan Younis, medics say
